1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Advanced Liver Fibrosis: new trials by email Literature Review of Advanced Liver Fibrosis trials Research Report on Advanced Liver Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Erlotinib for Hepatocellular Carcinoma Chemoprevention erlotinib hydrochloride, Placebo - Cirrhosis, Liver, Advanced Liver Fibrosis | Phase 2 | Not yet recruiting | University of Texas Southwestern Medical Center | 60 | 2026-12-01 | 2026-06-24 |
Carcinoma, Hepatocellular (1) · Liver Cirrhosis (1)
Adenocarcinoma (1) · Carcinoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Fibrosis (1) · Liver Diseases (1) · Liver Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
University of Texas Southwestern Medical Center (1)
United States (1)
Amit Singal, MD, MS (1) · Yujin Hoshida (1)
P50CA295495 (1)